Impact of Chronic Kidney Disease on Platelet Function Profiles in Diabetes Mellitus Patients With Coronary Artery Disease Taking Dual Antiplatelet Therapy

被引:199
作者
Angiolillo, Dominick J. [1 ]
Bernardo, Esther [2 ]
Capodanno, Davide [1 ]
Vivas, David [2 ]
Sabate, Manel [2 ]
Ferreiro, Jose Luis [1 ]
Ueno, Masafumi [1 ]
Jimenez-Quevedo, Pilar [2 ]
Alfonso, Fernando [2 ]
Bass, Theodore A. [1 ]
Macaya, Carlos [2 ]
Fernandez-Ortiz, Antonio [2 ]
机构
[1] Univ Florida, Coll Med, Jacksonville, FL 32209 USA
[2] San Carlos Univ Hosp, Cardiovasc Inst, Madrid, Spain
关键词
clopidogrel; chronic kidney disease; diabetes mellitus; platelets; GLYCOPROTEIN-IIB-IIIA; STENT THROMBOSIS; RENAL-INSUFFICIENCY; RISK-FACTORS; INDIVIDUAL RESPONSIVENESS; CARDIOVASCULAR OUTCOMES; UREMIC PATIENTS; ELUTING STENTS; LOW-RESPONDERS; CLOPIDOGREL;
D O I
10.1016/j.jacc.2009.10.043
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives We sought to assess the impact of renal function on platelet reactivity in patients with diabetes mellitus (DM) and coronary artery disease on aspirin and clopidogrel therapy. Background Diabetes mellitus is a key risk factor for chronic kidney disease (CKD). In aspirin-treated DM patients the presence of moderate/severe CKD is associated with reduced clinical efficacy of adjunctive clopidogrel therapy. Whether these findings may be attributed to differences in clopidogrel-induced effects is unknown. Methods This was a cross-sectional observational study in which DM patients taking maintenance aspirin and clopidogrel therapy were studied. Patients were categorized into 2 groups according to the presence or absence of moderate/severe CKD. Platelet aggregation after adenosine diphosphate (ADP) and collagen stimuli were assessed with light transmittance aggregometry and defined patients with high post-treatment platelet reactivity (HPPR). Markers of platelet activation, including glycoprotein IIb/IIIa activation and P-selectin expression, were also determined using flow cytometry. Results A total of 306 DM patients were analyzed. Patients with moderate/severe CKD (n = 84) had significantly higher ADP-induced (60 +/- 13% vs. 52 +/- 15%, p = 0.001) and collagen-induced (49 +/- 20% vs. 41 +/- 20%, p = 0.004) platelet aggregation compared with those without (n = 222). After adjustment for potential confounders, patients with moderate/severe CKD were more likely to have HPPR after ADP (adjusted odds ratio: 3.8, 95% confidence interval: 1.7 to 8.5, p = 0.001) and collagen (adjusted odds ratio: 2.4; 95% confidence interval: 1.1 to 5.4; p = 0.029) stimuli. Markers of platelet activation were significantly increased in patients with HPPR. Conclusions In DM patients with coronary artery disease taking maintenance aspirin and clopidogrel therapy, impaired renal function is associated with reduced clopidogrel-induced antiplatelet effects and a greater prevalence of HPPR. (J Am Coll Cardiol 2010;55:1139-46) (C) 2010 by the American College of Cardiology Foundation
引用
收藏
页码:1139 / 1146
页数:8
相关论文
共 50 条
  • [1] Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO
  • [2] 2-S
  • [3] Platelet function assessment to predict outcomes after coronary interventions - Hype or hope?
    Alfonso, Fernando
    Angiolillo, Dominick J.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 48 (09) : 1751 - 1754
  • [4] Elevated plasma fibrinogen and diabetes mellitus are associated with lower inhibition of platelet reactivity with clopidogrel
    Ang, Lawrence
    Palakodeti, Vachaspathi
    Khalid, Ahmer
    Tsimikas, Sotirios
    Idrees, Zaheib
    Tran, Phillip
    Clopton, Paul
    Zafar, Nayab
    Bromberg-Marin, Guilherme
    Keramati, Shahin
    Mahmud, Ehtisham
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 52 (13) : 1052 - 1059
  • [5] Platelet function profiles in patients with type 2 diabetes and coronary artery disease on combined aspirin and clopidogrel treatment
    Angiolillo, DJ
    Fernandez-Ortiz, A
    Bernardo, E
    Ramírez, C
    Sabaté, M
    Jimenez-Quevedo, P
    Hernández, R
    Moreno, R
    Escaned, J
    Alfonso, F
    Bañuelos, C
    Costa, MA
    Bass, TA
    Macaya, C
    [J]. DIABETES, 2005, 54 (08) : 2430 - 2435
  • [6] Identification of low responders to a 300-mg clopidogrel loading dose in patients undergoing coronary stenting
    Angiolillo, DJ
    Fernandez-Ortiz, A
    Bernardo, E
    Ramírez, C
    Barrera-Ramirez, C
    Sabaté, M
    Hernández, R
    Moreno, R
    Escaned, J
    Alfonso, F
    Bañuelos, C
    Costa, MA
    Bass, TA
    Macaya, C
    [J]. THROMBOSIS RESEARCH, 2005, 115 (1-2) : 101 - 108
  • [7] Impact of platelet reactivity on cardiovascular outcomes in patients with type 2 diabetes mellitus and coronary artery disease
    Angiolillo, Dominick J.
    Bernardo, Esther
    Sabate, Manel
    Jimenez-Quevedo, Pilar
    Costa, Marco A.
    Palazuelos, Jorge
    Hernandez-Antolin, Rosana
    Moreno, Raul
    Escaned, Javier
    Alfonso, Fernando
    Banuelos, Camino
    Guzman, Luis A.
    Bass, Theodore A.
    Macaya, Carlos
    Fernandez-Ortiz, Antonio
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 50 (16) : 1541 - 1547
  • [8] Randomized comparison of a high clopidogrel maintenance dose in patients with diabetes mellitus and coronary artery disease - Results of the Optimizing antiPlatelet Therapy In diabetes MellitUS (OPTIMUS) study
    Angiolillo, Dominick J.
    Shoemaker, Steven B.
    Desai, Bhaloo
    Yuan, Hang
    Charlton, Ronald K.
    Bernardo, Esther
    Zenni, Martin M.
    Guzman, Luis A.
    Bass, Theodore A.
    Costa, Marco A.
    [J]. CIRCULATION, 2007, 115 (06) : 708 - 716
  • [9] Variability in individual responsiveness to clopidogrel - Clinical implications, management, and future perspectives
    Angiolillo, Dominick J.
    Fernandez-Ortiz, Antonio
    Bernardo, Esther
    Alfonso, Fernando
    Macaya, Carlos
    Bass, Theodore A.
    Costa, Marco A.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (14) : 1505 - 1516
  • [10] Insulin therapy is associated with platelet dysfunction in patients with type 2 diabetes mellitus on dual oral antiplatelet treatment
    Angiolillo, Dominick J.
    Bernardo, Esther
    Ramirez, Celia
    Costa, Marco A.
    Sabate, Manel
    Jimenez-Quevedo, Pilar
    Hernandez, Rosana
    Moreno, Raul
    Escaned, Javier
    Alfonso, Fernando
    Banuelos, Camino
    Bass, Theodore A.
    Macaya, Carlos
    Fernandez-Ortiz, Antonio
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 48 (02) : 298 - 304